On Thursday, September 24, 2009, The Surgeon General of the U.S. Army released results from the Thai Phase III HIV vaccine study that demonstrated modest results in preventing HIV infection among participants in the clinical trial. The study found the vaccine regimen to be safe and 31 percent effective in preventing HIV infection.